NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
43547-296-03 | 43547-296 | HUMAN PRESCRIPTION DRUG | FEBUXOSTAT | febuxostat | TABLET | ORAL | 20230801 | N/A | ANDA | ANDA206266 | Solco Healthcare US LLC | FEBUXOSTAT | 80 mg/1 | 30 TABLET in 1 BOTTLE (43547-296-03) |
43547-296-09 | 43547-296 | HUMAN PRESCRIPTION DRUG | FEBUXOSTAT | febuxostat | TABLET | ORAL | 20230801 | N/A | ANDA | ANDA206266 | Solco Healthcare US LLC | FEBUXOSTAT | 80 mg/1 | 90 TABLET in 1 BOTTLE (43547-296-09) |
43547-296-50 | 43547-296 | HUMAN PRESCRIPTION DRUG | FEBUXOSTAT | febuxostat | TABLET | ORAL | 20230801 | N/A | ANDA | ANDA206266 | Solco Healthcare US LLC | FEBUXOSTAT | 80 mg/1 | 500 TABLET in 1 BOTTLE (43547-296-50) |
43547-295-50 | 43547-295 | HUMAN PRESCRIPTION DRUG | FEBUXOSTAT | febuxostat | TABLET | ORAL | 20230801 | N/A | ANDA | ANDA206266 | Solco Healthcare US LLC | FEBUXOSTAT | 40 mg/1 | 500 TABLET in 1 BOTTLE (43547-295-50) |
43547-295-09 | 43547-295 | HUMAN PRESCRIPTION DRUG | FEBUXOSTAT | febuxostat | TABLET | ORAL | 20230801 | N/A | ANDA | ANDA206266 | Solco Healthcare US LLC | FEBUXOSTAT | 40 mg/1 | 90 TABLET in 1 BOTTLE (43547-295-09) |
43547-295-03 | 43547-295 | HUMAN PRESCRIPTION DRUG | FEBUXOSTAT | febuxostat | TABLET | ORAL | 20230801 | N/A | ANDA | ANDA206266 | Solco Healthcare US LLC | FEBUXOSTAT | 40 mg/1 | 30 TABLET in 1 BOTTLE (43547-295-03) |